acute lymphoblastic leukaemia

Kite claims a first for CAR-T Tecartus in adult leukaemia

https://pharmaphorum.com/news/kite-claims-a-first-for-car-t-tecartus-in-adult-leukaemia/

ASCO21: Gilead sets up first FDA okay for CAR-T in adult ALL with Tecartus data

https://pharmaphorum.com/news/asco21-gilead-sets-up-first-fda-okay-for-adult-all-with-tecartus-data/

Real-world data backs Kymriah’s safety profile, says Novartis

https://pharmaphorum.com/news/real-world-data-backs-kymriahs-safety-profile-says-novartis/

Gilead expands CAR-T deal with MaxCyte, Precision files for $100m IPO

https://pharmaphorum.com/news/gilead-expands-car-t-deal-with-maxcyte-precision-files-for-100m-ipo/

Amgen’s blood cancer drug gets full EU licence

https://pharmaphorum.com/news/amgens-blood-cancer-drug-blincyto-licence/

NICE to reassess Pfizer blood cancer drug

https://pharmaphorum.com/news/nice-reassess-pfizer-blood-cancer-drug/

Novartis close to first-ever CAR-T approval after unanimous vote

https://pharmaphorum.com/news/novartis-car-t-ctl019-backed-fda-advisers/

Pfizer facing NICE showdown over leukaemia drug

https://pharmaphorum.com/news/pfizer-facing-nice-showdown-drug/

NICE backs Amgen’s Blincyto in rare leukaemia

https://pharmaphorum.com/news/nice-backs-amgens-blincyto-rare-leukaemia/

Close in 10 seconds

Pharmaphorum.com

Search